Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year-end Update and Financial Calendar

3 Jul 2019 12:24

RNS Number : 3825E
Craven House Capital PLC
03 July 2019
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Craven House Capital plc

 

("Craven House" or the "Company")

 

Year-end Update and Financial Calendar

 

Craven House Capital (AIM:CRV) is pleased to announce the following unaudited year-end investment update covering the year ending 31 May 2019.

 

Highlights

 

· Directors estimate that Net Asset Value ("NAV") per share has increased by 17% to $9.99 per share in the six-month period from November 2018 to May 2019.

 

· Changes in valuations reflect the previously announced repositioning of capital allocation and current investment focus in North America.

 

The table below sets out the latest estimate of the appropriate carrying value of the Company's investments as at 31 May 2019 in comparison to the values as of the latest published financial statements of the Company.

 

 

Investment

Estimated value at 31 May 19

(unaudited)

Value at 30 Nov 18 (unaudited)

 

 

 

Shares in Craven Industrial Holdings Plc

$27,605,161

$23,892,006

 

Comprising:

 

 

Shares in DLC Holdings Corp.

$8,757,041

$6,491,893

 Shares in Qeton Ltd

$650,206

$1,551,814

Shares in Craven House Angola LDA

$7,921,212

$8,903,150

Shares in Craven House Capital North America LLC

$7,907,782

$4,528,396

Shares in Kwikbuild Corporation Ltd

$2,368,919

$2,416,753

 

 

Portfolio update

 

The valuation of the Company's shareholding in Craven Industrial Holdings Plc ("CIH"), its principal wholly-owned investment holding company, has increased from $23.9m to $27.6m. This reflects the change in the respective value of subsidiary holdings as follows;

 

 

DLC Holdings Corp. (TSXV:DLC) - 68% owned by CRV

 

DLC is a Toronto Stock Exchange listed agricultural investment company with holdings in Brazil and South Africa. The valuation ascribed to CIH's shareholding in DLC in CRV's financial statements reflects the latest published share price of DLC's shares as of 31 May multiplied by the number of shares owned by CIH.

 

The valuation of DLC has increased due to an increase in the share price of DLC between Nov 18 and May 19.

 

 

Qeton Ltd ("Qeton") - 50% owned by CRV.

 

Qeton Ltd is a joint venture company focusing on the distribution of mobile phones, tablet computers and accessories into emerging markets.

 

The valuation of Qeton during the past six-month period has reduced from $1.55m to $0.650m reflecting a reduction in the earnings of Qeton during the period, with shares in Qeton valued at a multiple to net earnings based on the prior 12 months of trading. Whilst earnings have reduced, Qeton remains profitable and has a positive trading outlook.

 

 

Craven House Angola LDA ("CHA") - 100% owned by CRV.

 

Craven House Angola continued to provide local currency financing to Angolan subsidiaries of US and European companies in the consumer electronic and energy sectors. The carrying value of CHA's loan portfolio reduced from $8.9m to $7.9m during the six-month period to May 2019, reflecting the repayment of a portion of the outstanding loan facilities, in accordance with the terms of repayment. The proceeds of the repayments were passed to the parent company and utilized for general working capital purposes and for investment into Craven House's North American subsidiary.

 

Craven House Capital North America LLC ("CHNA") - 100% owned by CRV

 

The valuation of Craven's US investment holding company, CHNA, increased from $4.5m to $7.9m during the six months to May 2019. The majority of this increase reflects the successful sale of CHNA's wholly owned insurance business to LM Funding America Inc. ("LMFA") a NASDAQ listed entity as announced in January 2019. As of May 2019, CHNA owns c.25% of the common shares of LMFA and holds c.$3.6m in convertible notes in LMFA. CHNA also benefits from an equity portfolio valued at c.$3.5m, on a mark-to-market basis, as of May 2019.

 

 

 Kwikbuild Corporation Ltd. - 97% owned by CRV

 

There was little change in the valuation of Kwikbuild during the six-month period to the end of May 2019. The slight reduction in carrying value is the result of exchange rate movements and operating costs; the valuation of the underlying South African assets remained unchanged during this period. We continue with the process of liquidating our remaining holdings in South Africa.

 

 

Net Asset Value

 

As of the end of May 2019 the Directors estimate that the combined value of the other assets and liabilities of the Company represent a total liability of c.$2.6m. Of total liabilities of c.$3.6m, the majority (c.$2.4m) comprise intercompany loans or are due to related parties.

 

The approximate Net Asset Value of the Company therefore stood at c.$25.0m as of May 2019, equating to an NAV per share of $9.99 (vs. $8.57 as of November 2018). This estimate is prior to calculation of any performance fees due to the Investment Manager, which will be finalized following completion of the year-end audit.

 

Share buyback Update

 

The High Court has approved the reduction in share capital which is now subject to final formalities before being completed.

 

Financial Calendar

 

In order to provide shareholders with more regular information regarding the Company's investments, the Directors have decided to amend Craven House's reporting cycle to include, in addition to its interim and preliminary results, two further portfolio updates. These portfolio updates will occur shortly after the May year-end and November interim period in July and December respectively. This RNS forms the first of these new portfolio updates.

 

Going forward, the Company intends to follow the below financial timetable:

 

Anticipated date

Portfolio and NAV update

July

Preliminary financial results (for previous financial year)

Sept / Oct

Portfolio and NAV update

December

Interim Results

March

 

In addition to the above financial reporting calendar the Company will, in accordance with its obligations under the AIM Rules for Companies, make additional updates of matters which it considers appropriate. This may or may not include additional NAV updates.

 

 

 

~ Ends ~

 

 

For further information please contact:

 

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis/Mark Brady

www.Sparkadvisorypartners.com

 

Tel: 0203 368 3550

 

 

 

About Craven House Capital:

 

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGUUPMUPBGGW
Date   Source Headline
2nd Mar 20104:45 pmPRNAnnual Financial Report
26th Feb 20102:38 pmRNSInterim Results
18th Feb 20107:00 amPRNRe Agreement Investment Advisory
8th Feb 20104:46 pmRNSDirectorate Change
29th Jan 20102:34 pmRNSTotal Voting Rights
13th Jan 20103:43 pmRNSHolding(s) in Company
29th Dec 200911:43 amRNSInvesting Policy
22nd Oct 20097:00 amRNSDirectorate Change
16th Oct 20092:30 pmRNSCapitalisation of Loan
6th Oct 20094:57 pmRNSHolding(s) in Company
5th Oct 20092:45 pmRNSDirectors' Shareholding
28th Sep 200911:26 amRNSDirector Resignation
14th Sep 20094:39 pmPRNHalf-yearly Report
11th Sep 20093:39 pmRNSDirectorate Change
11th Sep 20093:26 pmRNSAGM Statement
31st Jul 200911:51 amRNSNotice of AGM
31st Jul 20097:00 amRNSAnnual Report
2nd Jun 200910:30 amRNSHoldings in Company
29th May 20094:04 pmRNSDirector Shareholding
26th May 20091:15 pmRNSChange of Adviser
20th May 20094:50 pmRNSDirector/PDMR Shareholding
20th May 20094:47 pmRNSre: Sub-Division of Shares
20th May 20097:00 amRNSDirectorate Change
15th May 20092:31 pmRNSTrading Statement
13th May 20099:43 amPRNIncrease in Performance Fees
11th May 20097:00 amRNSRestoration - Medsea Estates Group plc
8th May 20095:15 pmRNSChange of Adviser
30th Apr 20092:37 pmRNSResult of EGM
27th Apr 200911:44 amRNSAddendum and Appt of Director
22nd Apr 200910:30 amRNSDirectorate Change
6th Apr 200912:10 pmRNSResignation of Nomad and Broker
6th Apr 200912:10 pmRNSSuspension - Medsea Estates Group plc
19th Mar 20093:48 pmRNSTrading Update- Replacement
19th Mar 200911:45 amRNSTrading Update
1st Dec 200810:20 amRNSDirectorate Change
10th Nov 200810:45 amRNSUpdate re proposed delisting
30th Sep 20084:17 pmRNSTotal Voting Rights
30th Sep 20087:00 amRNSInterim Results
8th Sep 200811:00 amRNSProposed cancellation of AIM
4th Sep 200811:37 amRNSResult of AGM
1st Sep 20083:06 pmRNSDirectorate Change
13th Aug 20089:17 amRNSNotice of AGM
4th Jul 200810:47 amRNSDirector/PDMR Shareholding
30th Jun 20084:00 pmRNSAnnual Report and Accounts
30th Jun 20087:00 amRNSFinal Results
30th Apr 200811:03 amRNSUpdate re Report & Accounts
18th Feb 20083:00 pmRNSDirector/PDMR Shareholding
13th Feb 20083:04 pmRNSTrading Statement
23rd Nov 20077:01 amRNSDirectorate Change
28th Sep 20077:05 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.